Koji Kurose

595 total citations
27 papers, 418 citations indexed

About

Koji Kurose is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Koji Kurose has authored 27 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Koji Kurose's work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (6 papers). Koji Kurose is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (6 papers). Koji Kurose collaborates with scholars based in Japan, France and United Kingdom. Koji Kurose's co-authors include Mikio Oka, Yoshihiro Ohue, Midori Isobe, Eiichi Nakayama, Kazuhiro Kakimi, Ryuzo Ueda, Hisashi Wada, Hiroyoshi Nishikawa, Shinsuke Iida and Takeru Funakoshi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Koji Kurose

25 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koji Kurose Japan 10 289 228 55 52 34 27 418
Chris Hansell United Kingdom 10 324 1.1× 241 1.1× 29 0.5× 64 1.2× 30 0.9× 15 423
Lindsay K. Ward-Kavanagh United States 4 224 0.8× 142 0.6× 34 0.6× 73 1.4× 21 0.6× 5 344
Donghoon Choi South Korea 10 208 0.7× 173 0.8× 17 0.3× 54 1.0× 38 1.1× 19 314
Iwona Kwiecień Poland 13 194 0.7× 141 0.6× 68 1.2× 70 1.3× 32 0.9× 35 371
Jennifer T Ingram United States 8 287 1.0× 106 0.5× 49 0.9× 70 1.3× 60 1.8× 12 429
Kaixin Du China 9 115 0.4× 114 0.5× 51 0.9× 56 1.1× 71 2.1× 17 306
Anusha Muralidhar United States 6 152 0.5× 98 0.4× 29 0.5× 68 1.3× 28 0.8× 7 264
Kilian Wistuba‐Hamprecht Germany 13 368 1.3× 321 1.4× 43 0.8× 93 1.8× 66 1.9× 33 537
Mechthild Lütge Switzerland 12 325 1.1× 119 0.5× 35 0.6× 140 2.7× 19 0.6× 21 475
Oezcan Talay United States 7 281 1.0× 136 0.6× 16 0.3× 28 0.5× 27 0.8× 11 377

Countries citing papers authored by Koji Kurose

Since Specialization
Citations

This map shows the geographic impact of Koji Kurose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Kurose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Kurose more than expected).

Fields of papers citing papers by Koji Kurose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Kurose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Kurose. The network helps show where Koji Kurose may publish in the future.

Co-authorship network of co-authors of Koji Kurose

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Kurose. A scholar is included among the top collaborators of Koji Kurose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Kurose. Koji Kurose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saito, Takuro, Koji Kurose, Susumu Suzuki, et al.. (2025). Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors. Journal for ImmunoTherapy of Cancer. 13(4). e010634–e010634. 2 indexed citations
2.
Kurose, Koji, et al.. (2024). Analysis of the relationship between comorbid obstructive sleep apnea and clinical outcomes in patients with asthma in Japan. Allergology International. 73(3). 390–396. 5 indexed citations
3.
Yamaguchi, Kakuhiro, Koji Kurose, Satoshi Nakao, et al.. (2022). Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis. Respirology. 28(4). 380–388. 1 indexed citations
4.
5.
Nojima, Yuji, Katsuhiko Shimizu, Shinsuke Saisho, et al.. (2021). Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer. Anticancer Research. 41(11). 5469–5475. 4 indexed citations
6.
Saito, Takuro, Koji Kurose, Takashi Kojima, et al.. (2021). Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors.. PubMed. 83(4). 827–840. 13 indexed citations
7.
Kurose, Koji, et al.. (2020). Mechanical insufflation-exsufflation-related bilateral pneumothorax. Respiratory Medicine Case Reports. 29. 101017–101017. 3 indexed citations
8.
Kurose, Koji, et al.. (2020). Generalized herpes zoster and cutaneous metastasis during chemotherapy for non‐small cell lung cancer: A case report. Thoracic Cancer. 12(1). 117–121. 2 indexed citations
9.
Kurose, Koji, et al.. (2020). Detachment and recovery of an X-ray opaque tip of a disposable guide sheath kit: A rare complication of endobronchial ultrasound-guided transbronchial biopsy. Respiratory Medicine Case Reports. 29. 101030–101030. 1 indexed citations
10.
Endo, Shunji, Yoshinori Fujiwara, Koji Kurose, et al.. (2020). Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report. SHILAP Revista de lepidopterología. 6(1). 276–276.
11.
Ohue, Yoshihiro, Koji Kurose, Takahiro Karasaki, et al.. (2019). Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC. Journal of Thoracic Oncology. 14(12). 2071–2083. 34 indexed citations
12.
Kurose, Koji, et al.. (2017). Nivolumab-induced polyarthritis. BMJ Case Reports. 2017. bcr–2017. 3 indexed citations
13.
Ohue, Yoshihiro, Koji Kurose, Midori Isobe, et al.. (2016). Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells. Cancer Immunology Research. 4(12). 1049–1060. 40 indexed citations
14.
Kurose, Koji, Yoshihiro Ohue, Hisashi Wada, et al.. (2015). Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients. Clinical Cancer Research. 21(19). 4327–4336. 179 indexed citations
15.
Ohue, Yoshihiro, Koji Kurose, Hirofumi Matsumoto, et al.. (2014). Prolongation of Overall Survival in Advanced Lung Adenocarcinoma Patients with the XAGE1 (GAGED2a) Antibody. Clinical Cancer Research. 20(19). 5052–5063. 20 indexed citations
16.
Kurose, Koji, Yoshihiro Ohue, Eiichi Sato, et al.. (2014). Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760). Journal of Thoracic Oncology. 10(1). 74–83. 48 indexed citations
17.
Obase, Yasushi, Masaki Ikeda, Koji Kurose, et al.. (2013). Step-down of budesonide/formoterol in early stages of asthma treatment leads to insufficient anti-inflammatory effect. Journal of Asthma. 50(7). 718–721. 10 indexed citations
18.
Wakamatsu, Kazumasa, Shosuke Ito, Akiko Uenaka, et al.. (2013). TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD). Journal of Dermatological Science. 73(3). 209–215. 4 indexed citations
19.
Kurose, Koji, Shingo Eikawa, Yoshihiro Ohue, et al.. (2013). Abstract 4732: Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb.. Cancer Research. 73(8_Supplement). 4732–4732. 3 indexed citations
20.
Shimizu, Hiroki, Yasushi Obase, Masaki Ikeda, et al.. (2011). Stability of sealed-bag samples for off-line measurement of fractional exhaled nitric oxide. Annals of Allergy Asthma & Immunology. 106(5). 378–380. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Hansell Breakdown of academic impact, for papers by Lindsay K. Ward-Kavanagh Breakdown of academic impact, for papers by Donghoon Choi Breakdown of academic impact, for papers by Iwona Kwiecień Breakdown of academic impact, for papers by Jennifer T Ingram Breakdown of academic impact, for papers by Kaixin Du Breakdown of academic impact, for papers by Anusha Muralidhar Breakdown of academic impact, for papers by Kilian Wistuba‐Hamprecht Breakdown of academic impact, for papers by Mechthild Lütge Breakdown of academic impact, for papers by Oezcan Talay
Rankless by CCL
2026